Status:
COMPLETED
Reducing Operative and Post-operative Morbidity in Living Kidney Donors With the Airseal System
Lead Sponsor:
Yale University
Collaborating Sponsors:
SurgiQuest, Inc.
Conditions:
Pain
Eligibility:
All Genders
Phase:
NA
Brief Summary
The purpose of this study is to determine if the Airseal System will reduce post-operative pain and reduce the need for narcotics in laparoscopic living kidney donor surgeries.
Detailed Description
Our hypothesis is that Airseal Insufflation System will provide reduced mean operative insufflation pressure and operative mean ETCO2, resulting in improved post-operative pain control and improved op...
Eligibility Criteria
Inclusion
- Any living donor who has been approved to donate a kidney is eligible to participate.
Exclusion
- none
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2016
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT02262039
Start Date
August 1 2014
End Date
February 1 2016
Last Update
January 17 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale New Haven Transplantation Center
New Haven, Connecticut, United States, 06520